For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research ...
The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few ...
In this live interview on Bloomberg World, Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma, discusses the ...
Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles ...
Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" o ...
Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved ...
According to a new report published by Allied Market Research, titled, "Radiopharmaceuticals Market by End User, Radioisotope, Application, ...
News-Medical.Net on MSN
Human insight and AI advance prostate cancer treatment
Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...
Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results